SESSION TITLE: COPD Pharmacotherapy
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: A subanalysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) found different exacerbation profiles in patients with COPD enrolled in Asia vs the rest of the World (RoW). We aimed to determine if this was reflected in those enrolled in Asia excluding China (Asia exC) vs RoW.